Revance Therapeutics Inc (RVNC)
3.84
+0.04
(+1.05%)
USD |
NASDAQ |
Nov 21, 16:00
3.85
+0.01
(+0.26%)
Pre-Market: 09:19
Revance Therapeutics Market Cap: 402.83M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 402.83M |
| November 20, 2024 | 398.63M |
| November 19, 2024 | 394.43M |
| November 18, 2024 | 418.56M |
| November 15, 2024 | 437.44M |
| November 14, 2024 | 452.13M |
| November 13, 2024 | 444.79M |
| November 12, 2024 | 433.25M |
| November 11, 2024 | 361.91M |
| November 08, 2024 | 388.14M |
| November 07, 2024 | 606.34M |
| November 06, 2024 | 609.48M |
| November 05, 2024 | 612.63M |
| November 04, 2024 | 609.48M |
| November 01, 2024 | 608.43M |
| October 31, 2024 | 618.92M |
| October 30, 2024 | 620.98M |
| October 29, 2024 | 619.93M |
| October 28, 2024 | 618.88M |
| October 25, 2024 | 493.01M |
| October 24, 2024 | 555.95M |
| October 23, 2024 | 554.90M |
| October 22, 2024 | 554.90M |
| October 21, 2024 | 553.85M |
| October 18, 2024 | 554.90M |
| Date | Value |
|---|---|
| October 17, 2024 | 543.36M |
| October 16, 2024 | 553.85M |
| October 15, 2024 | 545.46M |
| October 14, 2024 | 539.16M |
| October 11, 2024 | 553.85M |
| October 10, 2024 | 551.75M |
| October 09, 2024 | 549.65M |
| October 08, 2024 | 547.56M |
| October 07, 2024 | 559.09M |
| October 04, 2024 | 547.56M |
| October 03, 2024 | 551.75M |
| October 02, 2024 | 544.41M |
| October 01, 2024 | 545.46M |
| September 30, 2024 | 544.41M |
| September 27, 2024 | 558.41M |
| September 26, 2024 | 561.53M |
| September 25, 2024 | 552.16M |
| September 24, 2024 | 572.47M |
| September 23, 2024 | 558.93M |
| September 20, 2024 | 605.29M |
| September 19, 2024 | 609.46M |
| September 18, 2024 | 624.04M |
| September 17, 2024 | 621.44M |
| September 16, 2024 | 621.96M |
| September 13, 2024 | 682.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
244.41M
Minimum
Jun 26 2024
3.161B
Maximum
May 09 2023
1.411B
Average
1.399B
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals Inc | 1.648B |
| Regeneron Pharmaceuticals Inc | 81.81B |
| MEI Pharma Inc | 18.72M |
| GlycoMimetics Inc | 20.63M |
| Anebulo Pharmaceuticals Inc | 38.90M |
Market Cap Related Metrics
| PS Ratio | 1.446 |
| Price | 3.84 |
| Earnings Yield | -50.52% |